Utah Community Builders frequently highlights businesses going above and beyond to make an impact in our community.
At the beginning of March, Utah-based pharmaceutical company Civica announced plans to both produce and distribute affordable insulin, an infamously expensive medicine essential for people with diabetes.
According to Civica’s website, “The availability of affordable insulins will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.”
In collaboration with other industry leading partners, the company plans to sell insulins at one low, transparent price for all, basing the price on the cost of development, production and distribution.
“Bold philanthropic partners have made it possible, with committed funds to date of over two-thirds of our $125M goal, for us to undertake this affordable insulin initiative,” said Ken Boyden, Executive Director of The Civica Foundation. “We are incredibly grateful for their leadership. They each have a passion for and commitment to building pathways to reliable drug access and affordability.”
In 2019, Civica established a headquarters in Lehi, Utah, with the goal of reducing and preventing drug shortages and the price spikes that can accompany them by making quality generic medicines accessible and affordable to everyone.
Utah Governor Spencer Cox complimented Civica’s efforts on Twitter, saying, “Families should never have to choose between life-saving medicine and things like food or housing. This is an incredible partnership and we are once again proud to see Utah companies leading the way.”
For more Spotlights on Doing Good, visit the UCB website.
